View Item 

Show simple item record

Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim- Sulfamethoxazole Induced Liver Injury
dc.contributor.authorLi, Yi‐ju
dc.contributor.authorPhillips, Elizabeth J.
dc.contributor.authorDellinger, Andrew
dc.contributor.authorNicoletti, Paola
dc.contributor.authorSchutte, Ryan
dc.contributor.authorLi, Danmeng
dc.contributor.authorOstrov, David A.
dc.contributor.authorFontana, Robert J.
dc.contributor.authorWatkins, Paul B.
dc.contributor.authorStolz, Andrew
dc.contributor.authorDaly, Ann K
dc.contributor.authorAithal, Guruprasad P
dc.contributor.authorBarnhart, Huiman
dc.contributor.authorChalasani, Naga
dc.date.accessioned2021-03-02T21:48:19Z
dc.date.available2022-02-02 16:48:17en
dc.date.available2021-03-02T21:48:19Z
dc.date.issued2021-01
dc.identifier.citationLi, Yi‐ju ; Phillips, Elizabeth J.; Dellinger, Andrew; Nicoletti, Paola; Schutte, Ryan; Li, Danmeng; Ostrov, David A.; Fontana, Robert J.; Watkins, Paul B.; Stolz, Andrew; Daly, Ann K; Aithal, Guruprasad P; Barnhart, Huiman; Chalasani, Naga (2021). "Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim- Sulfamethoxazole Induced Liver Injury." Hepatology (1): 268-281.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/166442
dc.publisherWiley Periodicals, Inc.
dc.publisherNational Institute of Diabetes and Digestive and Kidney Diseases
dc.titleHuman Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim- Sulfamethoxazole Induced Liver Injury
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166442/1/hep31258_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166442/2/hep31258-sup-0001-Materials.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/166442/3/hep31258.pdf
dc.identifier.doi10.1002/hep.31258
dc.identifier.sourceHepatology
dc.identifier.citedreferenceGonzalez- Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, da Silva AL, et al. update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res 2015; 43: D784 - D788.
dc.identifier.citedreferenceSibener LV, Fernandes RA, Kolawole EM, Carbone CB, Liu F, McAffee D, et al. Isolation of a structural mechanism for uncoupling T cell receptor signaling from peptide- MHC binding. Cell 2018; 174: 672 - 687.e27.
dc.identifier.citedreferenceMorris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785 - 2791.
dc.identifier.citedreferenceBjörnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug- induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40: 1095 - 1101.
dc.identifier.citedreferencePavlos R, Mallal S, Phillips E. HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics 2012; 13: 1285 - 1306.
dc.identifier.citedreferenceUrban TJ, Daly AK, Aithal GP. Genetic basis of drug- induced liver injury: present and future. Semin Liver Dis 2014; 34: 123 - 133.
dc.identifier.citedreferenceUrban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, et al.; Drug- Induced Liver Injury Network (DILIN); Pharmacogenetics of Drug- Induced Liver Injury group (DILIGEN); International Serious Adverse Events Consortium (iSAEC). Minocycline hepatotoxicity: Clinical characterization and identification of HLA- B*35:02 as a risk factor. J Hepatol 2017; 67: 137 - 144.
dc.identifier.citedreferenceNicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, et al.; International Drug- induced Liver Injury Consortium. HLA- DRB1*16: 01- DQB1*05: 02 is a novel genetic risk factor for flupirtine- induced liver injury. Pharmacogenet Genomics 2016; 26: 218 - 224.
dc.identifier.citedreferenceNicoletti P, Aithal GP, Bjornsson ES, Andrade RJ, Sawle A, Arrese M, et al.; International Drug- Induced Liver Injury Consortium; Drug- Induced Liver Injury Network Investigators; International Serious Adverse Events Consortium. Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome- wide association study. Gastroenterology 2017; 152: 1078 - 1089.
dc.identifier.citedreferenceà zkaya- Bayazit E, Akar U. Fixed drug eruption induced by trimethoprim- sulfamethoxazole: evidence for a link to HLA- A30 B13 Cw6 haplotype. J Am Acad Dermatol 2001; 45: 712 - 717.
dc.identifier.citedreferenceKongpan T, Mahasirimongkol S, Konyoung P, Kanjanawart S, Chumworathayi P, Wichukchinda N, et al. Candidate HLA genes for prediction of co- trimoxazole- induced severe cutaneous reactions. Pharmacogenet Genomics 2015; 25: 402 - 411.
dc.identifier.citedreferenceRochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug- induced liver injury. Hepatology 2008; 48: 1175 - 1183.
dc.identifier.citedreferenceFontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug- Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32: 55 - 68.
dc.identifier.citedreferenceAuton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al.; 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 2015; 526: 68 - 74.
dc.identifier.citedreferenceChalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug- induced liver injury in the United States. Gastroenterology 2008; 135: 1924 - 1934, 1934.e1- 4.
dc.identifier.citedreferenceZheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, et al. HIBAG- HLA genotype imputation with attribute bagging. Pharmacogenomics J 2014; 14: 192 - 200.
dc.identifier.citedreferenceMaiers M, Gragert L, Klitz W. High- resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007; 68: 779 - 788.
dc.identifier.citedreferenceBordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein structure homology modeling using SWISS- MODEL workspace. Nat Protoc 2009; 4: 1 - 13.
dc.identifier.citedreferenceBenjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289 - 300.
dc.identifier.citedreferenceSchaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425 - 434.
dc.identifier.citedreferenceHoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009; 61: 1 - 13.
dc.identifier.citedreferenceAithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug- induced liver injury. Clin Pharmacol Ther 2011; 89: 806 - 815.
dc.identifier.citedreferenceCirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, et al.; Drug- Induced Liver Injury Network (DILIN) investigators; International DILI consortium (iDILIC). A missense variant in PTPN22 is a risk factor for drug- induced liver injury. Gastroenterology 2019; 156: 1707 - 1716.e2.
dc.identifier.citedreferenceRobinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res 2015; 43: D423 - D431.
dc.identifier.citedreferenceKumar P, Vahedi- Faridi A, Saenger W, Merino E, Lopez de Castro JA, Uchanska- Ziegler B, et al. Structural basis for T cell alloreactivity among three HLA- B14 and HLA- B27 antigens. J Biol Chem 2009; 284: 29784 - 29797.
dc.identifier.citedreferenceLucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, et al.; Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin- clavulanate- induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011; 141: 338 - 347.
dc.identifier.citedreferenceSinger JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genome- wide study identifies HLA alleles associated with lumiracoxib- related liver injury. Nat Genet 2010; 42: 711 - 714.
dc.identifier.citedreferenceValenzuela- Ponce H, Alva- Hernandez S, Garrido- Rodriguez D, Soto- Nava M, Garcia- Téllez T, Escamilla- Gomez T, et al.; Mesoamerican HIV Project Group. Novel HLA class I associations with HIV- 1 control in a unique genetically admixed population. Sci Rep 2018; 8: 6111. https://doi.org/10.1038/s41598-018-23849-7. https://www.nature.com/srep/.
dc.identifier.citedreferencePereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, et al.; International HIV Controllers Study. The major genetic determinants of HIV- 1 control affect HLA class I peptide presentation. Science 2010; 330: 1551 - 1557.
dc.identifier.citedreferenceLi C, Rao T, Chen X, Zou Z, Wei A, Tang J, et al. HLA- B*35:01 allele is a potential biomarker for predicting polygonum multiflorum- induced liver injury in humans. Hepatology 2019; 70: 346 - 357.
dc.identifier.citedreferenceKarnes JH, Shaffer CM, Bastarache L, Gaudieri S, Glazer AM, Steiner HE, et al. Comparison of HLA allelic imputation programs. PLoS One 2017; 12: e0172444. https://doi.org/10.1371/journal.pone.0172444. https://journals.plos.org/plosone/.
dc.identifier.citedreferenceU.S. Food & Drug Admission. FDA approved drug: Bactrim. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017377s068s073lbl.pdf. Accessed April 2020.
dc.identifier.citedreferenceSulfamethoxazole- Trimethoprim. LiverTox: Clinical and Research Information on Drug- Induced Liver Injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017377s068s073lbl.pdf. Accessed April 2020.
dc.identifier.citedreferenceChalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al.; U.S. Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug- induced liver injury: the DILIN prospective study. Gastroenterology 2015; 148: 1340 - 1352.e7.
dc.identifier.citedreferenceChalasani N, Reddy KRK, Fontana RJ, Barnhart H, Gu J, Hayashi PH, et al. Idiosyncratic drug induced liver injury in African- Americans is associated with greater morbidity and mortality compared to Caucasians. Am J Gastroenterol 2017; 112: 1382 - 1388.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep31258_am.pdf
Size:
771.5KB
Format:
PDF
View/Open
Name:
hep31258-sup-0001-Materials.pdf
Size:
1.089MB
Format:
PDF
View/Open
Name:
hep31258.pdf
Size:
666.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.